Cromos Pharma has published a white paper that gives a comprehensive overview of clinical trial landscape in the Republic of Georgia, which is becoming a very attractive location for clinical trials
Cromos Pharma has published a white paper that gives a comprehensive overview of clinical trial landscape in the Republic of Georgia, which is becoming a very attractive location for clinical trials In addition to lightning-fast startup times, robust enrollment and full compliance with the ICH-GCP you will also be pleasantly surprised by the high quality of the study data evidenced by 12 recent 100% NAI (No Action Indicated) reports from FDA inspections. Please follow the link to the whitepaper that may provide some additional insight into
Meet Cromos Pharma’s CEO, Dr. Vlad Bogin in San Antonio, Texas at San Antonio Breast Cancer Symposium (SABCS 2016) on December 6-10, 2016
Cromos Pharma published a new article on Feasibilty in Applied Clinical Trials Journal We are delighted to announce that Applied Clinical Trials, the leading journal in its field has published our article that addresses the key issues facing the sponsor when choosing international clinical trial locations -‎ Feasibility in the Age of International Clinical Trials‎ by Vlad Bogin, MD, FACP We hope that you find the article informative
Meet Cromos Pharma’s CEO, Dr. Vlad Bogin in San Antonio, Texas at San Antonio Breast Cancer Symposium (SABCS 2016) on December 6-10, 2016
Cromos™ Pharma opens a representative office in Hungary BUDAPEST, HUNGARY–(Marketwired – Jan 11, 2016) –  Cromos™ Pharma, an international full-service CRO, has announced today that it has opened a representative office in Budapest, Hungary. “With a population of 10 million people, the highest standard of medical care and great investigator and patient engagement, Hungary exemplifies an excellent setting for global clinical research,” said

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us